Cargando…
Effect of Prucalopride on the Pharmacokinetics of Oral Contraceptives in Healthy Women
BACKGROUND: Prucalopride is a selective, high-affinity, 5-hydroxytryptamine 4 (5-HT(4)) receptor agonist, which is approved for the symptomatic treatment of chronic constipation in women in whom laxatives fail to provide adequate relief. Women of childbearing potential, many of whom will be using or...
Autores principales: | Van de Velde, Vera, Vandeplassche, Lieve, Hoppenbrouwers, Mieke, Boterman, Mark, Ausma, Jannie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing AG
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627014/ https://www.ncbi.nlm.nih.gov/pubmed/23539257 http://dx.doi.org/10.1007/s40268-013-0008-6 |
Ejemplares similares
-
Assessment of the cardiac safety of prucalopride in healthy volunteers: a randomized, double-blind, placebo- and positive-controlled thorough QT study
por: Mendzelevski, Boaz, et al.
Publicado: (2012) -
Effect of renal impairment on the pharmacokinetics of prucalopride: a single- dose open-label Phase I study
por: Smith, William B, et al.
Publicado: (2012) -
Prucalopride Improves Bowel Function and Colonic Transit Time in Patients With Chronic Constipation: An Integrated Analysis
por: Emmanuel, Anton, et al.
Publicado: (2014) -
Effect of prucalopride on symptoms of chronic constipation
por: Tack, J, et al.
Publicado: (2013) -
Development of a population pharmacokinetic model of prucalopride in children with functional constipation
por: van Schaick, Erno, et al.
Publicado: (2016)